iSonea reaches milestone with launch of U.S. paediatric asthma study – Proactive Investors USA & Canada


mobihealthnews

iSonea reaches milestone with launch of U.S. paediatric asthma study
Proactive Investors USA & Canada
iSonea (ASX: ISN, OTCQX: ISOAY) has begun its first large US post-market study of its WheezoMeter™ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too young to be tested with
iSonea Announces Initiation of Pediatric Asthma StudyMarketWatch (press release)
iSonea begins recruiting for pediatric asthma trialmobihealthnews
iSonea to Build Mobile Asthma Management Apps on Qualcomm's PlatformHighlight HEALTH 2.0

all 15 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.